Dr. Christopher Reist, MD

NPI: 1114972551
Total Payments
$13,323
2024 Payments
$4,263
Companies
7
Transactions
19

Payment Breakdown by Category

Other$7,381 (55.4%)
Consulting$4,050 (30.4%)
Travel$1,208 (9.1%)
Food & Beverage$684.46 (5.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,231 1 31.8%
Consulting Fee $4,050 2 30.4%
Honoraria $3,150 1 23.6%
Travel and Lodging $1,208 3 9.1%
Food and Beverage $684.46 12 5.1%

Top Paying Companies

Company Total Records Latest Year
H. Lundbeck A S $4,474 4 $0 (2019)
Boehringer Ingelheim International GmbH $4,231 1 $0 (2024)
Otsuka Pharmaceutical Development & Commercialization, Inc. $3,282 7 $0 (2024)
Janssen Pharmaceuticals, Inc $1,201 4 $0 (2017)
Sunovion Pharmaceuticals Inc. $83.35 1 $0 (2022)
Lundbeck LLC $27.86 1 $0 (2021)
Avanir Pharmaceuticals, Inc. $24.17 1 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $4,263 2 Boehringer Ingelheim International GmbH ($4,231)
2022 $148.64 3 Sunovion Pharmaceuticals Inc. ($83.35)
2021 $27.86 1 Lundbeck LLC ($27.86)
2020 $71.94 2 Otsuka Pharmaceutical Development & Commercialization, Inc. ($47.77)
2019 $7,507 6 H. Lundbeck A S ($4,474)
2018 $103.32 1 Otsuka Pharmaceutical Development & Commercialization, Inc. ($103.32)
2017 $1,201 4 Janssen Pharmaceuticals, Inc ($1,201)

All Payment Transactions

19 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/23/2024 Boehringer Ingelheim International GmbH Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $4,230.51 General
06/11/2024 Otsuka Pharmaceutical Development & Commercialization, Inc. Food and Beverage In-kind items and services $32.71 General
11/01/2022 Sunovion Pharmaceuticals Inc. Food and Beverage In-kind items and services $83.35 General
09/27/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Food and Beverage In-kind items and services $25.08 General
05/12/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $40.21 General
Category: PSYCHIATRY
09/23/2021 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $27.86 General
Category: PSYCHIATRY
02/28/2020 Avanir Pharmaceuticals, Inc. Food and Beverage In-kind items and services $24.17 General
02/05/2020 Otsuka Pharmaceutical Development & Commercialization, Inc. Food and Beverage In-kind items and services $47.77 General
11/07/2019 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $3,000.00 General
03/19/2019 Otsuka Pharmaceutical Development & Commercialization, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $32.99 General
Category: PSYCHIATRY
02/08/2019 H. Lundbeck A S REXULTI (Drug) Honoraria Cash or cash equivalent $3,150.00 General
Category: PSYCHIATRY
02/08/2019 H. Lundbeck A S REXULTI (Drug) Travel and Lodging Cash or cash equivalent $855.00 General
Category: PSYCHIATRY
02/08/2019 H. Lundbeck A S REXULTI (Drug) Travel and Lodging Cash or cash equivalent $323.65 General
Category: PSYCHIATRY
02/08/2019 H. Lundbeck A S REXULTI (Drug) Food and Beverage Cash or cash equivalent $145.00 General
Category: PSYCHIATRY
08/08/2018 Otsuka Pharmaceutical Development & Commercialization, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $103.32 General
Category: PSYCHIATRY
07/28/2017 Janssen Pharmaceuticals, Inc Consulting Fee Cash or cash equivalent $1,050.00 General
07/28/2017 Janssen Pharmaceuticals, Inc Food and Beverage In-kind items and services $115.00 General
07/28/2017 Janssen Pharmaceuticals, Inc Travel and Lodging Cash or cash equivalent $29.42 General
07/28/2017 Janssen Pharmaceuticals, Inc Food and Beverage Cash or cash equivalent $7.00 General

About Dr. Christopher Reist, MD

Dr. Christopher Reist, MD is a Psychiatry healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114972551.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Reist, MD has received a total of $13,323 in payments from pharmaceutical and medical device companies, with $4,263 received in 2024. These payments were reported across 19 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4,231).

Practice Information

  • Specialty Psychiatry
  • Location Long Beach, CA
  • Active Since 05/24/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1114972551

Products in Payments

  • REXULTI (Drug) $4,678

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Long Beach